Common Stocks - 97.4% |
| | Shares | Value ($) |
China - 34.5% | | | |
Advanced Micro-Fabrication Equipment, Inc., China (A Shares) | | 366,600 | 7,982,204 |
AK Medical Holdings Ltd. (a)(b) | | 4,066,765 | 2,248,658 |
Akeso, Inc. (a)(b)(c) | | 160,127 | 866,953 |
Alibaba Group Holding Ltd. | | 1,119,083 | 11,012,028 |
Alibaba Group Holding Ltd. sponsored ADR | | 54,500 | 4,297,325 |
Asymchem Laboratories Tianjin Co. Ltd.: | | | |
(A Shares) | | 39,521 | 405,843 |
(H Shares) (b) | | 97,100 | 584,749 |
Beijing Chunlizhengda Medical Instruments Co. Ltd. | | 239,600 | 426,118 |
Beijing Sinohytec Co. Ltd. (A Shares) | | 236,835 | 695,440 |
BYD Co. Ltd. (H Shares) | | 166,000 | 4,914,393 |
Empyrean Technology Co. Ltd. (A Shares) | | 66,000 | 719,809 |
Estun Automation Co. Ltd.: | | | |
(A Shares) | | 964,000 | 1,771,845 |
(A Shares) | | 406,600 | 747,336 |
Glodon Co. Ltd. (A Shares) | | 2,435,781 | 3,670,667 |
GRG Metrology & Test Co. Ltd. (A Shares) | | 374,269 | 652,661 |
Guangzhou Kingmed Diagnostics Group Co. Ltd. (A Shares) | | 149,356 | 602,616 |
Hangzhou Tigermed Consulting Co. Ltd. (A Shares) | | 122,208 | 906,605 |
Hygeia Healthcare Holdings Co. (a)(b) | | 134,600 | 362,650 |
Innovent Biologics, Inc. (b)(c) | | 337,470 | 1,671,617 |
Joinn Laboratories China Co. Ltd. (A Shares) | | 291,436 | 610,745 |
Kangji Medical Holdings Ltd. | | 643,038 | 469,140 |
Kanzhun Ltd. ADR | | 61,914 | 840,792 |
KE Holdings, Inc. ADR | | 86,806 | 1,202,263 |
Kindstar Globalgene Technology, Inc. (b) | | 2,605,082 | 450,138 |
Kingsemi Co. Ltd. (A Shares) | | 278,545 | 2,722,659 |
Kuaishou Technology Class B (b)(c) | | 284,539 | 1,595,168 |
Li Auto, Inc. ADR (a)(c) | | 159,031 | 3,139,272 |
Li Ning Co. Ltd. | | 998,954 | 1,866,762 |
Maxscend Microelectronics Co. Ltd. (A Shares) | | 56,200 | 600,551 |
Meituan Class B (b)(c) | | 370,772 | 5,133,958 |
Microport Cardioflow Medtech Corp. (a)(b)(c) | | 4,100,175 | 388,351 |
MicroPort NeuroTech Ltd. (a) | | 213,838 | 215,676 |
MicroTech Medical (Hangzhou) Co. Ltd. (H Shares) (b)(c) | | 525,611 | 252,282 |
NAURA Technology Group Co. Ltd. | | 137,973 | 6,547,256 |
NXP Semiconductors NV | | 16,012 | 4,213,718 |
PDD Holdings, Inc. ADR (c) | | 153,632 | 19,801,628 |
Ping An Insurance Group Co. of China Ltd. (H Shares) | | 985,043 | 4,277,669 |
SG Micro Corp. (A Shares) | | 34,500 | 376,550 |
Shandong Weigao Orthopaedic Device Co. Ltd. (A Shares) | | 870,100 | 2,474,207 |
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. (A Shares) | | 144,830 | 908,128 |
Shanghai MicroPort Endovascula MedTech Group Co. Ltd. (A Shares) | | 47,464 | 657,287 |
Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (A Shares) | | 119,639 | 4,260,588 |
Silergy Corp. | | 69,000 | 958,128 |
SITC International Holdings Co. Ltd. | | 561,041 | 1,249,495 |
Skyverse Technology Co. Ltd. | | 183,400 | 1,348,367 |
Smoore International Holdings Ltd. (a)(b) | | 791,437 | 924,864 |
SonoScape Medical Corp. | | 215,500 | 1,067,090 |
Tencent Holdings Ltd. | | 155,877 | 7,193,171 |
Tofflon Science & Technology Group Co. Ltd. (A Shares) | | 1,233,386 | 1,976,561 |
Trip.com Group Ltd. (c) | | 38,472 | 1,642,436 |
Venus MedTech Hangzhou, Inc. (H Shares) (a)(b)(c)(d) | | 1,074,577 | 618,378 |
Warom Technology, Inc. Co. | | 402,800 | 1,134,797 |
Weihai Guangwei Composites Co. Ltd. (A Shares) | | 291,744 | 1,139,942 |
WuXi AppTec Co. Ltd. (H Shares) (b) | | 440,346 | 1,806,395 |
Wuxi Biologics (Cayman), Inc. (b)(c) | | 419,679 | 613,846 |
WuXi XDC Cayman, Inc. (a) | | 2,271,881 | 5,205,101 |
Zai Lab Ltd. ADR (a)(c) | | 36,434 | 693,339 |
ZKH Group Ltd. (A Shares) (c) | | 9 | 1 |
Zylox-Tonbridge Medical Technology Co. Ltd. (b)(c) | | 605,892 | 814,282 |
TOTAL CHINA | | | 135,930,498 |
Hong Kong - 3.6% | | | |
AIA Group Ltd. | | 1,001,841 | 6,701,175 |
Hong Kong Exchanges and Clearing Ltd. | | 135,391 | 3,993,634 |
Huanxi Media Group Ltd. (a)(c) | | 9,140,292 | 678,545 |
J&T Global Express Ltd. (a) | | 3,837,163 | 3,020,479 |
TOTAL HONG KONG | | | 14,393,833 |
India - 25.4% | | | |
Amber Enterprises India Ltd. (c) | | 14,757 | 763,954 |
Aster DM Healthcare Ltd. (b) | | 141,756 | 587,576 |
Bajaj Finance Ltd. | | 19,083 | 1,551,421 |
Bharat Electronics Ltd. | | 417,188 | 1,574,773 |
Computer Age Management Services Private Ltd. | | 123,807 | 6,704,651 |
Delhivery Private Ltd. (c) | | 1,280,346 | 6,177,874 |
Devyani International Ltd. (c) | | 325,444 | 697,082 |
Eicher Motors Ltd. | | 24,474 | 1,450,619 |
GMR Airports Infrastructure Ltd. (c) | | 1,077,108 | 1,308,696 |
Go Digit General Insurance Ltd. | | 148,426 | 621,605 |
Go Digit General Insurance Ltd. | | 147,565 | 617,999 |
HDFC Asset Management Co. Ltd. (b) | | 79,578 | 3,910,335 |
HDFC Bank Ltd. | | 408,828 | 7,900,388 |
HDFC Standard Life Insurance Co. Ltd. (b) | | 279,392 | 2,387,558 |
Hindustan Aeronautics Ltd. | | 82,034 | 4,823,262 |
INOX India Ltd. | | 53,460 | 826,695 |
Juniper Hotels Ltd. | | 404,869 | 2,049,059 |
Kotak Mahindra Bank Ltd. | | 35,868 | 774,483 |
Larsen & Toubro Ltd. | | 27,471 | 1,251,697 |
MakeMyTrip Ltd. (a)(c) | | 213,874 | 20,016,468 |
Page Industries Ltd. | | 1,315 | 665,869 |
Reliance Industries Ltd. | | 205,397 | 7,386,072 |
Sapphire Foods India Ltd. (c) | | 59,743 | 1,178,658 |
SIS Ltd. (c) | | 162,271 | 826,978 |
SRF Ltd. | | 23,108 | 729,965 |
Syngene International Ltd. (b) | | 76,047 | 733,696 |
Tata Motors Ltd. | | 220,074 | 3,040,192 |
Tbo Tek Ltd. | | 2,302 | 50,486 |
Vijaya Diagnostic Centre Pvt Ltd. | | 54,106 | 510,928 |
Zomato Ltd. (c) | | 6,978,453 | 19,123,947 |
TOTAL INDIA | | | 100,242,986 |
Indonesia - 1.2% | | | |
PT Bank Central Asia Tbk | | 4,674,158 | 2,953,688 |
PT Bank Rakyat Indonesia (Persero) Tbk | | 5,887,598 | 1,694,098 |
TOTAL INDONESIA | | | 4,647,786 |
Japan - 0.9% | | | |
Freee KK (c) | | 72,962 | 1,188,880 |
Money Forward, Inc. (c) | | 68,511 | 2,262,891 |
TOTAL JAPAN | | | 3,451,771 |
Korea (South) - 10.0% | | | |
Delivery Hero AG (b)(c) | | 110,403 | 2,456,267 |
Gabia, Inc. | | 64,100 | 658,881 |
Kakao Corp. | | 32,441 | 928,381 |
Kakao Pay Corp. (c) | | 49,849 | 918,891 |
Kia Corp. | | 35,380 | 2,895,406 |
NAVER Corp. | | 28,079 | 3,566,785 |
Samsung Electronics Co. Ltd. | | 324,691 | 19,887,410 |
SK Hynix, Inc. | | 49,977 | 7,100,011 |
Webtoon Entertainment, Inc. | | 40,910 | 873,429 |
TOTAL KOREA (SOUTH) | | | 39,285,461 |
Netherlands - 0.7% | | | |
ASML Holding NV (Netherlands) | | 2,920 | 2,687,725 |
Singapore - 6.3% | | | |
Oversea-Chinese Banking Corp. Ltd. | | 149,727 | 1,663,384 |
Sea Ltd. ADR Class A (c) | | 334,978 | 22,008,055 |
United Overseas Bank Ltd. | | 51,594 | 1,248,647 |
TOTAL SINGAPORE | | | 24,920,086 |
Switzerland - 0.4% | | | |
Yunnan Botanee Bio-Technology Group Co. Ltd. ELS (UBS AG London Branch Bank Warrant Programme) Class A warrants 3/10/25 (b) | | 87,100 | 583,904 |
ZWSOFT Co. Ltd. Guangzhou (UBS AG London Branch Bank Warrant Programme) Class A warrants 9/25/25 (b) | | 97,608 | 900,405 |
TOTAL SWITZERLAND | | | 1,484,309 |
Taiwan - 12.8% | | | |
MediaTek, Inc. | | 41,000 | 1,568,314 |
Taiwan Semiconductor Manufacturing Co. Ltd. | | 1,540,393 | 45,131,629 |
Taiwan Semiconductor Manufacturing Co. Ltd. sponsored ADR | | 8,288 | 1,374,150 |
Unimicron Technology Corp. | | 392,000 | 2,193,932 |
TOTAL TAIWAN | | | 50,268,025 |
United Kingdom - 0.2% | | | |
Endava PLC ADR (c) | | 28,294 | 901,447 |
United States of America - 1.1% | | | |
ON Semiconductor Corp. (c) | | 26,912 | 2,105,864 |
Space Exploration Technologies Corp. (c)(d)(e) | | 6,000 | 672,000 |
Teradyne, Inc. | | 11,862 | 1,555,820 |
TOTAL UNITED STATES OF AMERICA | | | 4,333,684 |
Vietnam - 0.3% | | | |
Vietnam Dairy Products Corp. | | 491,921 | 1,394,913 |
TOTAL COMMON STOCKS (Cost $290,904,276) | | | 383,942,524 |
| | | |
Fiscal year to date information regarding the Fund's investments in Fidelity Central Funds, including the ownership percentage, is presented below.
Amounts in the dividend income column in the above table include any capital gain distributions from underlying funds.
Amounts in the dividend income column for Fidelity Securities Lending Cash Central Fund represents the income earned on investing cash collateral, less rebates paid to borrowers and any lending agent fees associated with the loan, plus any premium payments received for lending certain types of securities.
Investments are valued as of 4:00 p.m. Eastern time on the last calendar day of the period. Securities transactions are accounted for as of trade date. The Board of Trustees (the Board) has designated the Fund's investment adviser as the valuation designee responsible for the fair valuation function and performing fair value determinations as needed. The investment adviser has established a Fair Value Committee (the Committee) to carry out the day-to-day fair valuation responsibilities and has adopted policies and procedures to govern the fair valuation process and the activities of the Committee. In accordance with these fair valuation policies and procedures, which have been approved by the Board, the Fund attempts to obtain prices from one or more third party pricing services or brokers to value its investments. When current market prices, quotations or currency exchange rates are not readily available or reliable, investments will be fair valued in good faith by the Committee, in accordance with the policies and procedures. Factors used in determining fair value vary by investment type and may include market or investment specific events, transaction data, estimated cash flows, and market observations of comparable investments. The frequency that the fair valuation procedures are used cannot be predicted and they may be utilized to a significant extent. The Committee manages the Fund's fair valuation practices and maintains the fair valuation policies and procedures. The Fund's investment adviser reports to the Board information regarding the fair valuation process and related material matters.
The inputs to valuation techniques used to value investments are categorized into a disclosure hierarchy consisting of three levels as shown below:
Level 2 - other significant observable inputs (including quoted prices for similar investments, interest rates, prepayment speeds, etc.)
Level 3 - unobservable inputs (including the Fund's own assumptions based on the best information available)
Investments in any open-end mutual funds are valued at their closing net asset value (NAV) each business day and are categorized as Level 1 in the hierarchy.
Changes in valuation techniques may result in transfers in or out of an assigned level within the disclosure hierarchy.
For additional information on the Fund's significant accounting policies, please refer to the Fund's most recent semiannual or annual shareholder report.
The fund's schedule of investments as of the date on the cover of this report has not been audited. This report is provided for the general information of the fund's shareholders. For more information regarding the fund and its holdings, please see the fund's most recent prospectus and annual report.
Third party trademarks and service marks are the property of their respective owners. All other trademarks and service marks are the property of FMR LLC or an affiliate.